$13bn acquisition will give GlaxoSmithKline full ownership of the over-the-counter healthcare business
Consumer goods specialist Emma Walmsley will succeed Andrew Witty as the head of GlaxoSmithKline – the UK’s biggest pharmaceutical group
Sir Andrew Neil, the CEO of GlaxoSmithKline, has announced his intention to resign in March 2017, having served the company for eight years
The European CEO awards 2017 have now been announced, presenting our pick of the CEOs, companies and campaigns leading their sectors. View the winners here or browse the supplement in your browser or on your iPad or Android device.
